Weik Capital Management’s Elevance Health ELV Stock Holding History

Weik Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-4,000	Closed	-$398K	–	109
2014 Q1	$398K	Sell	4,000 -700	-15%	-$63.3K	0.25%	74
2013 Q4	$434K	Hold	4,700	–	–	0.27%	69
2013 Q3	$393K	Hold	4,700	–	–	0.26%	71
2013 Q2	$385K	Buy	+4,700	New	+$352K	0.27%	70

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Weik Capital Management's ELV Position: Q2 2014 in Review

Weik Capital Management sold out of Elevance Health (ELV) in Q2 2014, closing a stake of 4,000 shares — an estimated $398K sold.

Weik Capital Management first reported a position in ELV in Q2 2013 and held it in 4 quarters. The position peaked at $434K in Q4 2013. 687 funds tracked by Wall St. Rank hold ELV as of Q2 2014.

Weik Capital Management reported no remaining Elevance Health position as of Q2 2014 after selling out during the quarter.
Weik Capital Management sold 4,000 Elevance Health shares in Q2 2014, an estimated $398K.
Weik Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 4 quarters.
Weik Capital Management's Elevance Health position peaked at $434K in Q4 2013.
687 funds tracked by Wall St. Rank held Elevance Health as of Q2 2014.

Based on Weik Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.